Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01083433 · ClinicalTrials.gov registry record · NA

Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes

A NA study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
NA
Development phase
68
Enrollment target

NCT01083433: Completed NA study, sponsored by University Hospitals Cleveland Medical Center.

NCT01083433 is a NA study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 68 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01083433, a NA study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
NA
Development phase
68 participants
Enrollment target

Study Summary

The purpose of this research study is to find out ways to help pre-teens and teens and their families to improve diabetes control and to help with the burden of diabetes management. Specifically, the study aims to find out if coming to diabetes clinic more frequently and for a longer period of time helps adolescents with diabetes, and if adolescents who wear a continuous glucose monitor (CGM) for 3-5 days a month will have better diabetes control.

Primary Outcome

Serum hemoglobin A1c (HbA1c) will be measured in all groups at the baseline visit and visit 4.

Interventions

  • DEVICE Continuous Glucose Monitor
  • BEHAVIORAL Diabetes related psychological counseling and education

Trial Details

FieldValue
Enrollment Target 68 participants
Start Date 2010-05
Est. Completion 2011-10
Phase NA

What the finished NCT01083433 record still lists

NCT01083433 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which Continuous Glucose Monitor is the first listed.

NCT01083433 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01083433 about?

NCT01083433 is a clinical study titled "Study to Find Out if Intensive Diabetes Clinic and Continuous Glucose Monitors Help Teenagers With Diabetes". The purpose of this research study is to find out ways to help pre-teens and teens and their families to improve diabetes control and to help with the burden of diabetes management. Specifically, the study aims to find out if coming to diabetes clinic more frequently and for a longer period of time ...

What is the current status of trial NCT01083433?

This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2010-05. Estimated completion is 2011-10.

What interventions are being tested in trial NCT01083433?

The interventions under investigation include: Continuous Glucose Monitor (DEVICE), Diabetes related psychological counseling and education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01083433?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01083433's enrollment target sits among peer trials

68 1133rd of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02044497 · 68 participants · Phase 4

    Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients

  • NCT03779854 · 68 participants · Phase 2

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

  • NCT03821246 · 68 participants · Phase 2

    Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy

  • NCT04115514 · 68 participants · Phase 2

    Treatment of ARDS With Instilled T3

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01083433, the US trial registry maintained by the National Library of Medicine. NCT01083433 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.